Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Adagene Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 15 | 17 | +2 |
| Shares | 6.07M | 5.72M | −344.2K (−5.7%) |
| Value | $11.8M | $11.3M | −$590.4K (−5.0%) |
New holders (3)
Institutions that held Adagene Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 40,516 | $79.8K | 0.00% |
| XTX Topco Ltd | 10,909 | $21.5K | 0.00% |
| UBS Group AG | 2,806 | $5.58K | 0.00% |
Sold out (1)
Institutions that held Adagene Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| FMR LLC | 379,159 | $750.7K |